{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:09:56Z","timestamp":1778170196412,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":90,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/3\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.ctarc.2025.100922","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T21:01:46Z","timestamp":1743800506000},"page":"100922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Oncological outcomes and locoregional recurrence after fluorescence guided surgery for axillary staging in early breast cancer: A single UK center experience"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6051-6776","authenticated-orcid":false,"given":"Rahul","family":"Kanitkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilis","family":"Pitsinis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bushra","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Vinci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Hogg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee B.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2025.100922_bib0001","doi-asserted-by":"crossref","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch. Surg."},{"key":"10.1016\/j.ctarc.2025.100922_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/0960-7404(93)90064-6","article-title":"Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe","volume":"2","author":"Krag","year":"1993","journal-title":"Surg Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0003","first-page":"11","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","author":"Krag","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0004","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2025.100922_bib0005","first-page":"98","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial","author":"Mansel","year":"2006","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.ctarc.2025.100922_bib0006","doi-asserted-by":"crossref","DOI":"10.2325\/jbcs.12.211","article-title":"Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer","volume":"12","author":"Kitai","year":"2005","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ctarc.2025.100922_bib0007","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-012-2478-0","article-title":"A comparison of indocyanine green fluorescence imaging plus blue dye and blue dye alone for sentinel node navigation surgery in breast cancer patients","author":"Hirano","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0008","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.9159","article-title":"Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer","volume":"100","author":"Schaafsma","year":"2013","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.ctarc.2025.100922_bib0009","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-013-2890-0","article-title":"Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer","volume":"20","author":"Sugie","year":"2013","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0010","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-013-3437-0","article-title":"Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial","volume":"21","author":"Jung","year":"2014","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2006.04.016","article-title":"Axillary staging in women with small invasive breast tumours","volume":"32","author":"della Rovere","year":"2006","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0012","first-page":"247","article-title":"Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish multicenter cohort study","author":"Bergkvist","year":"2008","journal-title":"Ann Surg."},{"key":"10.1016\/j.ctarc.2025.100922_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2008.01.034","article-title":"Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature","author":"van der Ploeg","year":"2008","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0014","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-009-0704-1","article-title":"Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up","volume":"18","author":"Kiluk","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0015","unstructured":"Rous B. PGD 201124 2 V3 Final which leads on developing pathology guidance for the NHS Breast Screening Programme (NHSBSP) and for preparation of dataset standards in breast cancer pathology for the Royal. 2024."},{"key":"10.1016\/j.ctarc.2025.100922_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/cancers2020713","article-title":"A novel method for sentinel lymph node biopsy by indocyanine green fluorescence technique in breast cancer","volume":"2","author":"Sugie","year":"2010","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctarc.2025.100922_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2012.05.007","article-title":"A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer","volume":"38","author":"Wishart","year":"2012","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2015.10.002","article-title":"Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer","volume":"24","author":"Pitsinis","year":"2015","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0021","article-title":"A prospective study evaluating the accuracy of indocyanine green (ICG) fluorescence compared with radioisotope for sentinel lymph node (SLN) detection in early breast cancer","volume":"29","author":"Dumitru","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.21568","article-title":"Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis","author":"Kim","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ctarc.2025.100922_bib0023","doi-asserted-by":"crossref","DOI":"10.1093\/jjco\/29.12.604","article-title":"Sentinel node biopsy guided by indocyanin green dye in breast cancer patients","volume":"29","author":"Motomura","year":"1999","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0024","doi-asserted-by":"crossref","DOI":"10.2325\/jbcs.12.211","article-title":"Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer","volume":"12","author":"Kitai","year":"2005","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ctarc.2025.100922_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/1096-9098(200102)76:2<95::AID-JSO1018>3.0.CO;2-D","article-title":"Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients","volume":"76","author":"Motomura","year":"2001","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0026","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-024-16176-x","article-title":"Results of a prospective randomized multicenter study comparing indocyanine green (ICG) fluorescence combined with a standard tracer versus ICG alone for sentinel lymph node biopsy in early breast cancer: the INFLUENCE trial","author":"Pitsinis","year":"2024","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0027","first-page":"23","article-title":"Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer","author":"Inoue","year":"2016","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ctarc.2025.100922_bib0028","first-page":"19","article-title":"Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer","author":"Hojo","year":"2010","journal-title":"Breast"},{"key":"10.1016\/j.ctarc.2025.100922_bib0029","unstructured":"www.mhra.gov\/Safetyinformation\/DrugSafetyUpdate\/."},{"key":"10.1016\/j.ctarc.2025.100922_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2010.10.002","article-title":"Anaphylactic response to blue dye during sentinel lymph node biopsy","author":"B\u00e9zu","year":"2011","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(16)30311-4","article-title":"De-escalation of axillary surgery in early breast cancer","author":"Jatoi","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(10)70220-5","article-title":"An alternative to initial axillary-lymph-node dissection","author":"Benson","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0033","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2005.08.001","article-title":"American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer","author":"Lyman","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0034","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0b013e3182654494","article-title":"Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial","author":"Hunt","year":"2012","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ctarc.2025.100922_bib0035","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ctarc.2025.100922_bib0036","first-page":"121","article-title":"ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer","author":"Hirche","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ctarc.2025.100922_bib0037","first-page":"23","article-title":"Indocyanine green and methylene blue dye guided sentinel lymph node biopsy in early breast cancer: a single-center retrospective survival study in 1574 patients","author":"Yang","year":"2023","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.ctarc.2025.100922_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0039","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-012-2569-y","article-title":"Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000","volume":"20","author":"Sol\u00e1","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2025.100922_bib0040","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting axillary dissection in breast cancer with sentinel-node metastases","volume":"390","author":"de Boniface","year":"2024","journal-title":"N. Engl. J. Med."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225000590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225000590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:09:39Z","timestamp":1754060979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294225000590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":38,"alternative-id":["S2468294225000590"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100922","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncological outcomes and locoregional recurrence after fluorescence guided surgery for axillary staging in early breast cancer: A single UK center experience","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100922"}}